Keywords = FDA-approved, kinase inhibitors, FLT3 mutations
| Number of Articles: 1 | ||
| 1 | AML and FLT3: An Update on FDA-approved or Under Review Kinase Inhibitors Targeting FLT3 Kinase | |
| Volume 67, Issue 5, May 2024, Page 529-553 | ||
| Nada Alaa El-Deen; Eman M.E. Dokla; Mai Youssef Jaballah; Khaled Abouzid; Rabah Ahmed Serya | ||
View on SCiNiTO